Related News

No related news articles were found.

hester biosciences ltd (HBIO) Related Businessweek News

No Related Businessweek News Found

hester biosciences ltd (HBIO) Details

Hester Biosciences Limited manufactures, markets, and exports animal vaccines and health products in India and internationally. The company offers live vaccines for avians, swine, and large animals; inactivated vaccines for avians; and health products for avians and large animals. It also provides seroprofiling services to producers for evaluating the immune response to administered vaccines and/or to obtain evidence of flock exposure to field strains; and mastitis control programs for the cattle, as well as offers diagnostics products. Hester Biosciences Limited was founded in 1987 and is based in Ahmedabad, India.

hester biosciences ltd (HBIO) Key Developments

Hester Biosciences Ltd. announced that in the Board Meeting held on July 22, 2015, Mr. Amit Shukla have been appointed as an Alternate Director of the company for Dr. Siba Samal.

Hester Biosciences Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for the Remaining Quarters of the Financial Year 2016

Jul 22 15

Hester Biosciences Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported manufacturing sales (net of excise duty) was INR 218.43 million against INR 217.48 million a year ago. Net sales/income from operations was INR 245.29 million against INR 233.04 million a year ago. Profit from operations before other income, finance cost, and exceptional items was INR 68.38 million against INR 64.57 million a year ago. Profit from ordinary activities before tax was INR 56.43 million against INR 55.05 million a year ago. Net profit from ordinary activities after tax was INR 46.63 million against INR 43.43 million a year ago. Basic and diluted EPS was INR 5.48 against INR 5.11 a year ago. EBITDA was 33.34% compared to 31.26% a year ago.
The company expects a higher growth rate for the remaining quarters of the financial year 2016.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.